(3S,4S,5S,10S,13R)-4,10,13-Trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

Term ID

CHEBI:181919

Synonyms

(3S,4S,5S,10S,13R)-4,10,13-trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

Definition

References

KEGG:C05103

Ontology

ChEBI ( EBI )

Relationships

is a type of: cholestanoid

cholestanoid Show first 5 Terms

Phenotype

Phenotype resulting from (3S,4S,5S,10S,13R)-4,10,13-Trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

Phenotype where environments contain (3S,4S,5S,10S,13R)-4,10,13-Trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

Phenotype modified by environments containing (3S,4S,5S,10S,13R)-4,10,13-Trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

Human Disease Model